Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy.

Honami SatoTakahiro KobayashiYoshihiro KameokaKazuaki TeshimaAtsushi WatanabeMasahiro YamadaTakaya YamashitaShinsuke NoguchiYoshihiro MichisitaNaohito FujishimaJun KurokiNaoto Takahashi

Published in: International journal of clinical oncology (2024)

This study demonstrates that WT1 mRNA dynamics can be a useful marker for assessing long-term prognosis of VEN combination therapy for AML.

Keyphrases

acute myeloid leukemia
combination therapy
peripheral blood
allogeneic hematopoietic stem cell transplantation
chronic lymphocytic leukemia